New cream trial aims to soothe painful side effect of cervical cancer treatment
NCT ID NCT07492654
Summary
This study is testing whether a cream called triethanolamine can prevent or reduce vaginal inflammation (radiation vaginitis) caused by radiotherapy for cervical cancer. Researchers will compare the cream plus standard care against standard care alone in about 238 patients. The main goal is to see if the cream lowers how often and how severe the inflammation gets, while also checking its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VAGINITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.